Related Experiment Video

Updated: Mar 27, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR

Published on: May 16, 2012

25.2K

MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility

Deyao Wu1, Xiaobing Niu1, Huixing Pan1

  • 1Department of Urology, The Fourth Affiliated Hospital of Nantong Medical College, Yancheng City No. 1 People's Hospital, Yancheng, Jiangsu 224001, P.R. China.

Molecular Medicine Reports
|January 20, 2016
PubMed

Insights

MicroRNA-497 (miR-497) suppresses prostate cancer progression by inhibiting cell migration and invasion. Restoring miR-497 levels may offer a new therapeutic approach for prostate cancer by downregulating hepatoma-derived growth factor (HDGF).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-497 (miR-497) is frequently downregulated in various cancers, including prostate cancer.
  • Understanding the tumor suppressor mechanisms of miR-497 is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional role and molecular mechanism of miR-497 in prostate cancer.
  • To determine if miR-497 directly targets hepatoma-derived growth factor (HDGF) in prostate cancer cells.

Main Methods:

  • Prostate cancer cell lines (DU145 and PC-3) were transfected with miR-497 mimics.
  • Cell migration and invasion were assessed using Transwell assays.
  • Protein expression levels were analyzed by western blot, and direct targeting was confirmed via luciferase assays.

Main Results:

  • miR-497 transfection significantly inhibited the migration and invasion capabilities of prostate cancer cells.
  • Hepatoma-derived growth factor (HDGF) was identified as a direct target of miR-497 in these cells.
  • Downregulation of HDGF was observed following miR-497 restoration.

Conclusions:

  • miR-497 functions as a tumor suppressor in prostate cancer by inhibiting cell motility.
  • The miR-497/HDGF axis represents a potential therapeutic target for prostate cancer treatment.
  • Restoring miR-497 levels offers a promising strategy for managing prostate cancer progression.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K